Crossmark

Estimaciones de la incidencia de las neoplasias hematológicas en España, 2021: estudio de la Red Española de Registros de Cáncer (REDECAN)

Crossref DOI link: https://doi.org/10.1016/j.medcli.2021.09.035

Published Print: 2022-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Sanvisens, Arantza

Ameijide, Alberto

Carulla, Marià

Marcos-Gragera, Rafael
Funding

Funding for this research was provided by:

AGAUR

Institut de Recerca Contra la Leucemia Josep Carreras
License Information

Text and Data Mining valid from 2022-03-01

stm-asf valid from 2022-03-01

stm-asf valid from 2022-03-01

stm-asf valid from 2022-03-01

stm-asf valid from 2022-03-01

stm-asf valid from 2022-03-01
More Information

This article is maintained by: Elsevier

Article Title: Estimaciones de la incidencia de las neoplasias hematológicas en España, 2021: estudio de la Red Española de Registros de Cáncer (REDECAN)

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2021.09.035

Content Type: article

Copyright: © 2021 Elsevier España, S.L.U. All rights reserved.